Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BrAVA: Angemin vs Activelle on Postmenopausal Breast Density
NCT00785317Phase 4Unknown
- Sponsor
- Karolinska Institutet
- Start
- Nov 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estradiol + drospirenone in menopause (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Mammographic breast density at 6 months. Status: unknown.
02
Drugs
estradiol + drospirenone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00785317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785317.